Emicizumab

ATC B02BX06 · 9 markets · 36 records

Emicizumab 9 markets · 36 records Forms

US 6 records · 6 strengths

CA 6 records · 6 strengths

GB 5 records · 5 strengths

AU 5 records · 5 strengths

  • 30 mginjectionHEMLIBRA emicizumab (rch) 105 mg/0.7 mL solution for injection vial also in US·TW unknown
  • 150 mginjectionHEMLIBRA emicizumab (rch) 105 mg/0.7 mL solution for injection vial also in US unknown
  • 105 mginjectionHEMLIBRA emicizumab (rch) 105 mg/0.7 mL solution for injection vial unknown
  • 60 mginjectionHEMLIBRA emicizumab (rch) 105 mg/0.7 mL solution for injection vial unknown

Records without a stated strength · 1 Hemlibra

ES 5 records · 2 strengths

HK 4 records · 1 strengths

    Records without a stated strength · 1 HEMLIBRA SOLUTION FOR INJECTION 105MG/0.7ML

    SG 2 records · 2 strengths

    TW 2 records · 2 strengths

    Records without a stated strength · 1 HEMLIBRA SC Injection 30 mg/mL、血甯博皮下注射劑150毫克/毫升

    EU 1 records · 1 strengths

    EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

      Records without a stated strength · 1 Hemlibra

      Side-by-side table

      The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

      Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.